GOCO Quote, Financials, Valuation and Earnings

eHealth has a net margin of -2% compared to GoHealth's net margin of 1.72%. GoHealth's return on equity of 0.44% beat eHealth's return on equity of 4.17%.

GoHealth has a consensus price target of $21.60, signalling upside risk potential of 265.48%. On the other hand eHealth has an analysts' consensus of $10.00 which suggests that it could grow by 166.67%. Given that GoHealth has higher upside potential than eHealth, analysts believe GoHealth is more attractive than eHealth.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison eHealth has a beta of 0.969, suggesting its less volatile than the S&P 500 by 3.055%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -- of its earnings as a dividend. eHealth pays out 55.3% of its earnings as a dividend. eHealth's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

GoHealth quarterly revenues are $221M, which are larger than eHealth quarterly revenues of $113.1M. GoHealth's net income of -$4.4M is lower than eHealth's net income of $2M. Notably, GoHealth's price-to-earnings ratio is -- while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.08x versus 0.20x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Goosehead Insurance has a net margin of -2% compared to GoHealth's net margin of 3.1%. GoHealth's return on equity of 0.44% beat Goosehead Insurance's return on equity of 228.38%.

GoHealth has a consensus price target of $21.60, signalling upside risk potential of 265.48%. On the other hand Goosehead Insurance has an analysts' consensus of $116.44 which suggests that it could grow by 15.31%. Given that GoHealth has higher upside potential than Goosehead Insurance, analysts believe GoHealth is more attractive than Goosehead Insurance.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Goosehead Insurance has a beta of 1.418, suggesting its more volatile than the S&P 500 by 41.779%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Goosehead Insurance offers a yield of 0% to investors and pays a quarterly dividend of $5.91 per share. GoHealth pays -- of its earnings as a dividend. Goosehead Insurance pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $221M, which are larger than Goosehead Insurance quarterly revenues of $75.6M. GoHealth's net income of -$4.4M is lower than Goosehead Insurance's net income of $2.3M. Notably, GoHealth's price-to-earnings ratio is -- while Goosehead Insurance's PE ratio is 84.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.08x versus 10.88x for Goosehead Insurance. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of -2% compared to GoHealth's net margin of 7.69%. GoHealth's return on equity of 0.44% beat Kingstone Companies's return on equity of 36.5%.

GoHealth has a consensus price target of $21.60, signalling upside risk potential of 265.48%. On the other hand Kingstone Companies has an analysts' consensus of $22.00 which suggests that it could grow by 47.75%. Given that GoHealth has higher upside potential than Kingstone Companies, analysts believe GoHealth is more attractive than Kingstone Companies.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.571, suggesting its less volatile than the S&P 500 by 42.923%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -- of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $221M, which are larger than Kingstone Companies quarterly revenues of $50.5M. GoHealth's net income of -$4.4M is lower than Kingstone Companies's net income of $3.9M. Notably, GoHealth's price-to-earnings ratio is -- while Kingstone Companies's PE ratio is 9.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.08x versus 1.14x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Reliance Global Group has a net margin of -2% compared to GoHealth's net margin of -41%. GoHealth's return on equity of 0.44% beat Reliance Global Group's return on equity of -205.56%.

GoHealth has a consensus price target of $21.60, signalling upside risk potential of 265.48%. On the other hand Reliance Global Group has an analysts' consensus of -- which suggests that it could grow by 8339.72%. Given that Reliance Global Group has higher upside potential than GoHealth, analysts believe Reliance Global Group is more attractive than GoHealth.

GoHealth has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Reliance Global Group has a beta of -0.327, suggesting its less volatile than the S&P 500 by 132.653%.

GoHealth has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reliance Global Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoHealth pays -- of its earnings as a dividend. Reliance Global Group pays out -- of its earnings as a dividend.

GoHealth quarterly revenues are $221M, which are larger than Reliance Global Group quarterly revenues of $4.2M. GoHealth's net income of -$4.4M is lower than Reliance Global Group's net income of -$1.7M. Notably, GoHealth's price-to-earnings ratio is -- while Reliance Global Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoHealth is 0.08x versus 0.17x for Reliance Global Group. Usually stocks with elevated PS ratios are considered overvalued.